Given the complexity, increasing recognition/prevalence and suboptimal understanding of MAC lung disease, can you summarize for us the disease burden, epidemiology, risk factors, and unmet needs for this infectious condition?

Given the complexity, increasing recognition/prevalence and suboptimal understanding of MAC lung disease, can you summarize for us the disease burden, epidemiology, risk factors, and unmet needs for this infectious condition?

Given the complexity, increasing recognition/prevalence and suboptimal understanding of MAC lung disease, can you summarize for us the disease burden, epidemiology, risk factors, and unmet needs for this infectious condition?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Patrick Flume, MD

Patrick Flume, MD

Professor of Medicine and Pediatrics Medical University of South Carolina Powers-Huggins Endowed Chair for Cystic Fibrosis University of South Carolina Charleston, South Carolina